Literature DB >> 28961352

Therapeutic alliance in psychological therapy for people with schizophrenia and related psychoses: A systematic review.

Lucy Shattock1, Katherine Berry1, Amy Degnan1, Dawn Edge1.   

Abstract

Therapeutic alliance is a key predictor of therapy outcomes. Alliance may be particularly pertinent for people with schizophrenia as this group often have a history of interpersonal trauma and relationship difficulties including difficult relationships with mental health staff. This review aimed to determine (a) the quality of therapeutic alliance between people with schizophrenia and their therapists; (b) whether alliance predicts therapeutic outcomes; and (c) variables associated with alliance. Databases were searched from inception up to April 2015. The search yielded 4,586 articles, resulting in 26 eligible studies, involving 18 independent samples. Weighted average client and therapist Working Alliance Inventory-Short Form total scores were 64.51 and 61.26, respectively. There was evidence that alliance predicts overall psychotic symptomatic outcomes and preliminary evidence for alliance predicting rehospitalization, medication use, and self-esteem outcomes. There was evidence for specific client-related factors being linked to different perspectives of alliance. For example, poorer insight and previous sexual abuse were associated with worse client-rated alliance, whereas baseline negative symptoms were associated with worse therapist-rated alliance. Therapist and therapy-related factors, including therapists' genuineness, trustworthiness, and empathy were associated with better client-rated alliance, whereas suitability for therapy, homework compliance, and attendance were associated with better therapist-rated alliance. Key clinical implications include the need to consider alliance from both client and therapist perspectives during therapy and training and supervision to enhance therapist qualities that foster good alliance. Future research requires longitudinal studies with larger samples that include pan-theoretical, well-validated alliance measures to determine causal predictor variables.
Copyright © 2017 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2017        PMID: 28961352     DOI: 10.1002/cpp.2135

Source DB:  PubMed          Journal:  Clin Psychol Psychother        ISSN: 1063-3995


  6 in total

1.  Relationships Between Working Alliance and Outcomes in Group Therapy for People Diagnosed with Schizophrenia.

Authors:  Danielle M Beaudette; Lisa N Cruz; Alicia Lukachko; Matthew Roché; Steven M Silverstein
Journal:  Psychosis       Date:  2020-06-16

2.  Association between Therapeutic Alliance and Adherence in Outpatient Schizophrenia Patients.

Authors:  Jhin Goo Chang; Daeyoung Roh; Chan-Hyung Kim
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-05-31       Impact factor: 2.582

Review 3.  What can clinicians do to improve outcomes across psychiatric treatments: a conceptual review of non-specific components.

Authors:  S Priebe; M Conneely; R McCabe; V Bird
Journal:  Epidemiol Psychiatr Sci       Date:  2019-08-15       Impact factor: 6.892

4.  Improving Medication Adherence in Community-Dwelling Patients with Schizophrenia Through Therapeutic Alliance and Medication Attitude: A Serial Multiple Mediation Model.

Authors:  Wen Ling Hsieh; Shin Ting Yeh; Wen I Liu; I Hsien Li; Shih Kai Lee; Wai Tong Chien
Journal:  Patient Prefer Adherence       Date:  2022-04-13       Impact factor: 2.314

Review 5.  The relationship between the therapeutic alliance in psychotherapy and suicidal experiences: A systematic review.

Authors:  Charlotte Huggett; Patricia Gooding; Gillian Haddock; Jody Quigley; Daniel Pratt
Journal:  Clin Psychol Psychother       Date:  2022-02-25

6.  Theory of mind, emotion recognition, delusions and the quality of the therapeutic relationship in patients with psychosis - a secondary analysis of a randomized-controlled therapy trial.

Authors:  Stephanie Mehl; Klaus Hesse; Anna-Christine Schmidt; Martin W Landsberg; Daniel Soll; Andreas Bechdolf; Jutta Herrlich; Tilo Kircher; Stefan Klingberg; Bernhard W Müller; Georg Wiedemann; Andreas Wittorf; Wolfgang Wölwer; Michael Wagner
Journal:  BMC Psychiatry       Date:  2020-02-10       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.